devrimb / iStockphoto.com
Erica Pascal of DLA Piper investigates the patentability of machine learning and its outcomes, and the complex issues that may arise.
This content is only available to readers with a subscription.
For access to weekly features, regular news and our LSIPR print publications – subscribe here.
News stories up to a week old on LSIPR are accessible with a BASIC FREE ACCOUNT.
Feature articles are FREE to access on the day they are published with a BASIC FREE ACCOUNT. After then you will need to take out a paid subscription. A free trial will give you access to all website content for two weeks.
If you have already subscribed please login.
learning, machine, software, drug, method, patentability, computer, discovery, USPTO, erica pascal, DLA Piper, biological